The suppressive effects of ultraviolet radiation on immunity in the skin and internal organs: Implications for autoimmunity

Journal of Dermatological Science

Volumn 66, Issue 3, 2012, Pages 176-182

  Halliday, Gary M ^a   Damian, Diona L ^a   Rana, Sabita ^a,b   Byrne, Scott N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Patan Academy of Health Sciences   (Nepal)

Author keywords

Autoimmune disorders; Photoimmunosuppression; Skin cancer; Ultraviolet radiation; UVA; UVB

Indexed keywords

REACTIVE OXYGEN METABOLITE; UROCANIC ACID;

AUTOIMMUNITY; BONE MARROW; CELL ACTIVATION; CELL ACTIVITY; CELL EXPANSION; CHROMATOPHORE; CYTOTOXIC T LYMPHOCYTE; DNA DAMAGE; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; MEMORY T LYMPHOCYTE; NONHUMAN; ORGAN SYSTEMS; PRIORITY JOURNAL; PROVOCATION TEST; RADIATION DOSE; REVIEW; SKIN; SPLEEN; SUNLIGHT; SUPPRESSOR CELL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MODELS, ANIMAL; SKIN; SKIN NEOPLASMS; SPLEEN; ULTRAVIOLET RAYS;

EID: 84861346699     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.12.009     Document Type: Review

References (50)

1. Norval M., Halliday G.M. The consequences of UV-induced immunosuppression for human health. Photochem Photobiol 2011, 87:965-977.
2. Halliday G.M., Byrne S.N., Damian D.L. Ultraviolet A radiation: its role in immunosuppression and carcinogenesis. Semin Cutan Med Surg 2011, 30:214-221.
3. Hart P.H., Gorman S., Finlay-Jones J.J. Modulation of the immune system by UV radiation: more than just the effects of vitamin D?. Nat Rev Immunol 2011, 11:584-596.
4. Damian D.L., Barnetson R.S., Halliday G.M. Measurement of in vivo sunscreen immune protection factors in humans. Photochem Photobiol 1999, 70:910-915.
5. Rana S., Byrne S.N., Macdonald L.J., Chan C.Y., Halliday G.M. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol 2008, 172:993-1004.
6. Damian D.L., Halliday G.M. Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002, 28:34-45.
7. Poon T.S.C., Barnetson R.S.C., Halliday G.M. Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects. J Invest Dermatol 2005, 125:840-846.
8. Sivapirabu G., Yiasemides E., Halliday G.M., Park J., Damian D.L. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2009, 161:1357-1364.
9. Moyal D.D., Fourtanier A.M. Broad-spectrum sunscreens provide better protection from the suppression of the elicitation phase of delayed-type hypersensitivity response in humans. J Invest Dermatol 2001, 117:1186-1192.
10. Matthews Y.J., Halliday G.M., Phan T.A., Damian D.L. A UVB wavelength dependency for local suppression of recall immunity in humans demonstrates a peak at 300nm. J Invest Dermatol 2010, 130:1680-1684.
11. Matthews Y.J., Halliday G.M., Phan T.A., Damian D.L. Wavelength dependency for UVA-induced suppression of recall immunity in humans. J Dermatol Sci 2010, 59:192-197.
12. Damian D.L., Matthews Y.J., Phan T.A., Halliday G.M. An action spectrum for ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2011, 164:657-659.
13. Byrne S.N., Spinks N., Halliday G.M. Ultraviolet A irradiation of C57BL/6 mice suppresses systemic contact hypersensitivity or enhances secondary immunity depending on dose. J Invest Dermatol 2002, 119:858-864.
14. Byrne S.N., Spinks N., Halliday G.M. The induction of immunity to a protein antigen using an adjuvant is significantly compromised by ultraviolet A radiation. J Photochem Photobiol B: Biol 2006, 84:128-134.
15. Stapelberg M.P.F., Williams R.B.H., Byrne S.N., Halliday G.M. The alternative complement pathway seems to be a UVA sensor that leads to systemic immunosuppression. J Invest Dermatol 2009, 129:2694-2701.
16. Anders A., Altheide H.J., Knalmann M., Tronnier H. Action spectrum for erythema in humans investigated with dye lasers. Photochem Photobiol 1995, 61:200-205.
17. Young A.R., Chadwick C.A., Harrison G.I., Nikaido O., Ramsden J., Potten C.S. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. J Invest Dermatol 1998, 111:982-988.
18. Wolf P., Cox P., Yarosh D.B., Kripke M.L. Sunscreens and T4N5 liposomes differ in their ability to protect against ultraviolet-induced sunburn cell formation, alterations of dendritic epidermal cells, and local suppression of contact hypersensitivity. J Invest Dermatol 1995, 104:287-292.
19. Zastrow L., Groth N., Klein F., Kockott D., Lademann J., Ferrero L. UV, visible and infrared light. Which wavelengths produce oxidative stress in human skin?. Hautarzt 2009, 60:310-317.
20. Kvam E., Tyrrell R.M. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 1997, 18:2379-2384.
21. McLoone P., Simics E., Barton A., Norval M., Gibbs N.K. An action spectrum for the production of cis-urocanic acid in human skin in vivo. J Invest Dermatol 2005, 124:1071-1074.
22. Zhou J., Jang Y.P., Kim S.R., Sparrow J.R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci USA 2006, 103:16182-16187.
23. Park J., Halliday G.M., Surjana D., Damian D.L. Nicotinamide prevents ultraviolet radiation-induced cellular energy loss. Photochem Photobiol 2010, 86:942-948.
24. Yiasemides E., Sivapirabu G., Halliday G.M., Park J., Damian D.L. Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis 2009, 30:101-105.
25. Kuchel J.M., Barnetson R.S., Halliday G.M. Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochem Photobiol Sci 2005, 4:577-582.
26. Ullrich S.E. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005, 571:185-205.
27. Byrne S.N., Beaugie C., O'Sullivan C., Leighton S., Halliday G.M. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. Am J Pathol 2011, 179:211-222.
28. Fukunaga A., Khaskhely N.M., Ma Y., Sreevidya C.S., Taguchi K., Nishigori C., et al. Langerhans cells serve as immunoregulatory cells by activating NKT cells. J Immunol 2010, 185:4633-4640.
29. Toichi E., Lu K.Q., Swick A.R., McCormick T.S., Cooper K.D. Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin. J Invest Dermatol 2008, 128:2705-2715.
30. Hart P.H., Grimbaldeston M.A., Swift G.J., Jaksic A., Noonan F.P., Finlay-Jones J.J. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 1998, 187:2045-2053.
31. Byrne S.N., Limon-Flores A.Y., Ullrich S.E. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 2008, 180:4648-4655.
32. Byrne S.N., Halliday G.M. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J Invest Dermatol 2005, 124:570-578.
33. Ng R.L.X., Bisley J.L., Gorman S., Norval M., Hart P.H. Ultraviolet irradiation of mice reduces the competency of bone marrow-derived CD11c(+) cells via an indomethacin-inhibitable pathway. J Immunol 2010, 185:7207-7215.
34. Moodycliffe A.M., Nghiem D., Clydesdale G., Ullrich S.E. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000, 1:521-525.
35. Rana S., Rogers L.J., Halliday G.M. Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms. Am J Pathol 2011, 178:2783-2791.
36. Toda M., Wang L., Ogura S., Torii M., Kurachi M., Kakimi K., et al. UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses. Int J Cancer 2011, 129:1126-1136.
37. McGlade J.P., Strickland D.H., Lambert M.J., Gorman S., Thomas J.A., Judge M.A., et al. UV inhibits allergic airways disease in mice by reducing effector CD4 T cells. Clin Exp Allergy 2010, 40:772-785.
38. Moloney F.J., Comber H., O'Lorcain P., O'Kelly P., Conlon P.J., Murphy G.M. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006, 154:498-504.
39. Lembo S., Fallon J., O'Kelly P., Murphy G.M. Polymorphic light eruption and skin cancer prevalence: is one protective against the other?. Br J Dermatol 2008, 159:1342-1347.
40. Yoshikawa T., Rae V., Bruins-Slot W., Van den Berg J.W., Taylor J.R., Streilein J.W. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990, 95:530-536.
41. Loser K., Mehling A., Loeser S., Apelt J., Kuhn A., Grabbe S., et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006, 12:1372-1380.
42. Mohr S.B., Garland C.F., Gorham E.D., Garland F.C. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008, 51:1391-1398.
43. van der Mei I.A.F., Ponsonby A.L., Dwyer T., Blizzard L., Simmons R., Taylor B.V., et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J 2003, 327:316-320.
44. Sloka S., Silva C., Pryse-Phillips W., Patten S., Metz L., Yong V.W. A quantitative analysis of suspected environmental causes of MS. Can J Neurol Sci 2011, 38:98-105.
45. Lucas R.M., Ponsonby A.L., Dear K., Valery P.C., Pender M.P., Taylor B.V., et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011, 76:540-548.
46. Polderman M.C., Le Cessie S., Huizinga T.W., Pavel S. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxf) 2004, 43:1402-1404.
47. McGrath H., Smith J.L., Bak E., Michalski J.P. Ultraviolet-A light in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 1987, 5:323-328.
48. McGrath H., Bak E., Michalski J.P. Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black×New Zealand white) F1 hybrid mice. Arthritis Rheum 1987, 30:557-561.
49. Fivenson D.P. The mechanisms of action of nicotinamide and zinc in inflammatory skin disease. Cutis 2006, 77:5-10.
50. Damian D.L., Patterson C.R.S., Stapelberg M., Park J., Barnetson R.S.C., Halliday G.M. UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 2008, 128:447-454.